Co-Create Intelligence

We at Optima Insights believe that actionable intelligence holds the key to improved ROI for our clients. Hence we follow an innovative engagement model, by understanding the issues facing their business and work with them to create targeted research solutions at compelling price point. We offer a most effective and comprehensive way to develop a research study as we work as an extended arm of client's internal research team.

Co-Create Intelligence


Optima Insight's databook provides you prioritized, validated and first hand information along with expert commentaries in a tabular form to help you visualize the global pharmaceutical market and understand investment opportunities. We cover an exclusive portfolio of 20 major therapeutic categories and 50 leading therapeutic segments.

- R&D Pipeline Tracker: Optima Insight’s pharma pipeline products databook helps you to effectively monitor competitor pipelines, appraise trial evidence, evaluate products in development and assess commercial potential of upcoming products. We have introduced exclusive new fields such as launch year, timing of peak sales of experimental drugs, clinical risk, probability of clinical success & expert commentaries on promising drug classes and its impact on approved treatments.

- Marketed Products Tracker: Optima Insight’s branded product databook will be useful for analyzing current and projected sales performance, drug classes and Mechanism of Action (MoA) and approved indications. We have introduced exclusive new fields such as peak sales, patent expiries and expert commentaries to help you optimize your therapeutic franchise strategies.

- Pipeline Milestone Tracker : Optima Insight's Pipeline Milestone Tracker helps you to identify investment opportunities in the biotechnology and pharmaceutical industry by assessing the relative strength of companies’ clinical drug pipelines with timing of the future events that impact stock price movements.

- Biosimilar Pipeline Tracker : Optima Insights offer a comprehensive biosimilar tracker that covers the annual cost of treatments, expected launch year, patent expires of originators, market size of the reference drugs with commentaries to formulate effective strategies and gain competitive advantage. $200bn biologics market offer strong addressable biosimilar market opportunities in the foreseeable future for players across the spectrum. This is fueled by the development of regulatory pathways across the world, upcoming patent expiries, growing acceptance from physicians and rising price sensitive environment. The market is going to heat up with complex biosimilars starting to reach the market in oncology and Immunology & Inflammations.

- Late-Stage Game Changer Tracker : Optima Insight’s late-stage game changers tracker covers innovative, late-stage, and first-in-class products that offer high unmet medical need of leading global companies. Among other fields, the tracker provides 2022 consensus sales estimates and 2026 estimated peak sales.

Request for Demo

Reports Store

Get unlimited access to a range of reports from the report store from an exclusive portfolio of 20 major therapeutic categories and 50 leading therapeutic segments facing the global pharmaceutical industry at the click of a button.

Latest Tweets

Coming Soon...

Contact Us

  • Address:
    Optima Insights Pvt. Ltd.
    #1 MMC, Road, Chennai. Pin - 600060 
    Tamil Nadu.
    I N D I A.

  • Phone:
    +1 424 2554 365 (US)
           +91 966 6620 365

  • Strategic Research Support throughout the year


Follow Us